Diagnos Inc.
DGNOF
$0.189
-$0.0047-2.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.65% | -7.51% | -15.96% | -42.72% | 12.70% |
| Total Depreciation and Amortization | 10.50% | -6.81% | -0.42% | 1.72% | -1.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.68% | -44.77% | 41.53% | 1.31% | -8.82% |
| Change in Net Operating Assets | 112.08% | 53.35% | -162.13% | 204.95% | -478.43% |
| Cash from Operations | 24.47% | -10.83% | -97.14% | 29.21% | -45.19% |
| Capital Expenditure | -64.71% | 43.33% | 42.31% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 580.04% | 54.35% | 51.50% | -200.99% | -350.27% |
| Cash from Investing | 575.57% | 54.29% | 51.46% | -202.41% | -352.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -133.28% | -519.48% | -11.38% | 5.26% | 0.00% |
| Issuance of Common Stock | -- | 25.57% | -38.76% | 93.42% | 135.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.84% | 19.33% | -0.94% | 1.72% | -3.28% |
| Cash from Financing | -143.80% | 10.53% | -42.30% | 103.48% | 166.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.72% | 104.22% | -215.96% | 536.70% | -170.38% |